SureNano Science — Proxy Solicitation & Information Statement 2025

Jul 17, 2025

SURENANO SCIENCE LTD.
350 – 1650 West 2nd Ave
Vancouver, B.C. V6J 1H4

NOTICE OF MEETING

ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF SURENANO SCIENCE LTD. TO BE HELD ON AUGUST 8, 2025

NOTICE IS HEREBY GIVEN that an Annual General and Special Meeting (the "Meeting") of the Shareholders of SURENANO SCIENCE LTD. (the "Company") will be held in the Boardroom of Owen Bird Law Corporation, 29th Floor, 733 Seymour Street, Vancouver, British Columbia, on Friday, August 8, 2025, at 11:30 a.m. (Pacific time), for the following purposes:

1. to receive the audited financial statements of the Company for the fiscal years ended March 31, 2024 and March 31, 2025;
2. to appoint Buckley Dodds CPA as the Company's auditor for the fiscal year ending March 31, 2026 and to authorize the Board of Directors to fix the remuneration to be paid to the auditor;
3. to set the number of directors of the Company at four (4);
4. to elect the directors of the Company to hold office until the next annual general meeting of Shareholders of the Company;
5. to consider and, if deemed appropriate, to pass, with or without variation, an ordinary resolution ratifying and approving the Company's Omnibus Long-Term Incentive Plan, as more particularly described in the Information Circular (as hereinafter defined) and approval of the unallocated rights and entitlements under such plan; and
6. to transact such other business as may properly be brought before the Meeting or any adjournment(s) or postponement(s) thereof.

Accompanying this Notice is an Information Circular dated July 2, 2025 (the "Information Circular"), a form of proxy or voting instruction form, and a reply card for use by shareholders who wish to receive the Company's interim and/or annual financial statements. The Information Circular provides information relating to the matters to be addressed at the meeting and is incorporated into this Notice.

Registered shareholders who are unable to attend the Meeting in person and who wish to ensure that their shares will be voted at the Meeting are requested to complete, date and sign the enclosed form of proxy, or another suitable form of proxy and deliver it in accordance with the instructions set out in the form of proxy and in the Information Circular.

Non-registered shareholders who plan to attend the Meeting must follow the instructions set out in the form of proxy or voting instruction form to ensure that their shares will be voted at the Meeting. If you hold your shares in a brokerage account, you are not a registered shareholder.

Dated at Vancouver, British Columbia as of July 2, 2025.

BY ORDER OF THE BOARD OF DIRECTORS

"Charles MaLette"

Charles MaLette
President, Chief Executive Officer,
Corporate Secretary and Director